PDF herunterladen
Exp Clin Endocrinol Diabetes 2001; 109(Suppl 2): S180-S188
DOI: 10.1055/s-2001-18580
Physiology - Metabolism - Pathophysiology

© Johann Ambrosius Barth

Pathogenesis of dyslipidemia in type 2 diabetes

M.-R. Taskinen
  • Department of Medicine, University of Helsinki, Helsinki, Finland
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
23. November 2001 (online)

Auch verfügbar auf
  als PDF herunterladen  Lizenzen und Reprints

Summary:

The recognition that hypertriglyceridemia is associated with multiple alterations of other lipoproteins that are potentially atherogenic has expanded the picture of diabetic dyslipidemia. Elevation of large VLDL1 particles initiate a sequency of events that results in generation of atherogenic lipoproteins including remnants and small dense LDL. This abnormality is also associated with the lowering of HDL cholesterol. The clinical implication is that the concentration of plasma triglycerides should be maintained as low as possible to avoid these deleterious consequences of hypertriglyceridemia.

Key words:

Type 2 diabetes - lipoproteins - apoproteins - small dense LDL